Agios Cancer ‘Metabolism’ Drug Clears Bone Marrow of Leukemic Cells – TheStreet

A second experimental drug from Agios Pharmaceuticals (AGIO) designed to attack the “metabolism” of cancer cells has demonstrated early but strong clinical responses in a study involving patients with advanced leukemia.